Insider Monkey77d agoneutral
Gilead’s Revenue Is Accelerating, But are its Acquisitions Worth the Cost?News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
105last 24h
3124last 7d
510● bullish (7d)
311● bearish (7d)
227publishers
Barrons.com96d agoneutral
Gilead Posts a Loss on Acquisitions but Revenue Tells a Bigger StoryInsider Monkey167d agoneutral
Gilead Sciences (GILD) Acquires Tubulis for $3.15B to Expand Oncology PortfolioSimply Wall St.183d agoneutral
Stronger HIV Pipeline And Acquisition Charges Might Change The Case For Investing In Gilead Sciences (GILD)Reuters185d agobearish
Gilead raises 2026 sales forecast, cuts profit outlook due to acquisitions